Handelsavisen
prelaunch
KV
KVT.WA Warsaw Stock Exchange Non-Alcoholic Beverages

Krynica Vitamin SA

$13,00
Open in Charts → Attach watcher ⌖
PLN
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
159,3M PLN
P/E
12,1x
EV / Rev
0,6x
Div yield
2,12 %
Op margin
-0,9 %
ROE
-1,4 %
Net margin
-1,4 %
Debt / equity
0,66
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Krynica Vitamin SA is a Polish manufacturer and distributor of vitamin and mineral supplements, primarily operating in the non-alcoholic beverages and health food sectors.

Business. Krynica Vitamin SA (KVT.WA) is a Polish company engaged in the non-alcoholic beverages industry, operating within the broader food and beverages sector. The firm is headquartered in Poland and is primarily listed on the Warsaw Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Beverages
IndustryNon-Alcoholic Beverages
ActivityFood & Beverages
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
12,1x
P/E
Analysts
not yet wired
Ownership
not yet wired
Profitability
-1,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning KVT.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to KVT.WA. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Krynica Vitamin SA (KVT.WA) is a Polish company engaged in the non-alcoholic beverages industry, operating within the broader food and beverages sector. The firm is headquartered in Poland and is primarily listed on the Warsaw Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Beverages
    IndustryNon-Alcoholic Beverages
    ActivityFood & Beverages
    AI synthesis
    GENERATED

    Krynica Vitamin's capital structure shows a debt-to-equity ratio of 0.66, indicating a moderate reliance on debt financing. The company's liquidity position is weak, with a current ratio of 0.82 and only PLN 599,000 in cash and equivalents, which is significantly lower than its total liabilities of PLN 145.86 million. The company's price-to-book ratio of 1.94 suggests that the market values the company at a premium to its book value, but this is not supported by strong profitability metrics.

    Profitability metrics are concerning, with a negative return on equity (ROE) of -1.41% and a negative return on assets (ROA) of -0.5%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income is negative at PLN -739,000, and the net income is also negative at PLN -1.14 million, which is far below the industry median for profitability.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the risk associated with the company's revenue streams, as it is highly dependent on the performance of its primary market. The company's revenue of PLN 82.18 million is derived from the production and sale of vitamin and mineral supplements, with no significant international operations reported.

    The company's growth trajectory is uncertain, with a negative operating income and net income in the latest reporting period. The outlook for the current fiscal year (FY) is not provided, but the negative financial performance suggests a challenging environment. The company's free cash flow of PLN 1.19 million is modest and may not be sufficient to fund future growth initiatives or debt obligations. The capital expenditure of PLN -1.11 million indicates some investment in the business, but it is not enough to offset the negative operating results.

    Risk factors include the company's weak liquidity position and negative net cash after subtracting total debt. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative financial performance and high debt levels pose significant operational and financial risks. The company's ability to generate positive cash flows and improve its profitability will be critical in mitigating these risks.

    Recent events and disclosures include the latest actual EPS of 0.58 PLN and revenue of 296.78 million PLN, as reported by analysts. These figures suggest that the company's performance is below expectations, and there is a need for strategic improvements to enhance profitability and cash flow generation. The company's financial health is closely tied to its ability to manage costs and increase sales in its primary market.

    Key takeaways
    • Krynica Vitamin has a weak liquidity position with a current ratio of 0.82 and negative net cash after debt.
    • The company is unprofitable, with a negative ROE of -1.41% and a negative net income of PLN -1.14 million.
    • Revenue is concentrated in a single business segment with no significant geographic diversification.
    • The company's growth trajectory is uncertain, with negative operating and net income in the latest reporting period.
    • The risk assessment highlights medium liquidity risk and low dilution risk, but the company's financial performance is a major concern.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Long-term debt decreased significantly to PLN 26.5 million in 2020, indicating improved leverage management compared to prior periods.

    Free cash flow turned positive to PLN 17.4 million in 2020, demonstrating operational cash generation capability despite net losses.

    The company maintains a debt-to-equity ratio of 0.66, which is below the cohort median of 0.18, suggesting manageable leverage.

    Dilution risk is assessed as low, providing some protection for existing shareholders against equity value erosion.

    Capex to revenue ratio of -1.35% is above the 75th percentile, indicating lower capital intensity than peers.

    BEAR CASE · 3

    Credit risk is flagged as high, indicating substantial potential for financial distress or default issues for the company.

    Return on equity stands at negative 1.41%, placing the company in the bottom quartile of its non-alcoholic beverage cohort.

    Revenue declined 4.8% year-over-year to PLN 359.2 million, showing an inability to maintain top-line growth momentum.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2019-11-12
    Q3 2019 · Quarter highlights

    Revenue PLN 100.8M, −10,7% YoY; Operating income −18,1% YoY.

    RevenuePLN 100.8M−10,7 % YoY
    Operating incomePLN 7.0M−18,1 % YoY
    Net incomePLN 5.0M−23,8 % YoY
    Free cash flowPLN 7.4M−17,7 % YoY
    EPS
    Operating cash flowPLN 19.9M−42,8 % YoY
    Financials
    Income statement
    RevenuePLN 100.8M
    Gross profitPLN 18.5M
    Operating incomePLN 7.0M
    Net incomePLN 5.0M
    Margins
    Gross margin18.4%
    Operating margin6.9%
    Net margin5.0%
    FCF margin7.3%
    Balance sheet
    Total assetsPLN 207.2M
    Total liabilitiesPLN 104.2M
    Total equityPLN 103.0M
    Cash & equivalentsPLN 70.0k
    Long-term debtPLN 33.7M
    Cash flow
    Operating cash flowPLN 19.9M
    CapEx-PLN 3.7M
    Free cash flowPLN 7.4M
    SBC
    P&L flow · revenue → net income
    Revenue PLN 100.8MOperating costs PLN 93.8MTax PLN 1.9MNet income PLN 5.0M
    Highlights
    • Revenue PLN 100.8M, −10,7% YoY
    • Operating income −18,1% YoY
    • Net income −23,8% YoY
    • Free cash flow −17,7% YoY
    • Net margin 5.0%

    Valuation TTM

    Market price
    $13,00
    Market cap
    $156.8M
    Enterprise value
    $209.6M
    P/E
    12.1x
    Non-GAAP P/E
    EV / Revenue
    0.6x
    EV / Op income
    12.0x
    EV / OCF
    44.8x
    P / B
    1.9x
    P / Tangible book
    1.9x
    Tangible book
    $80.7M
    Net cash
    -$52.8M
    Current ratio
    0.8
    Debt / equity
    0.7
    ROA
    -0.5%
    ROE
    -1.4%
    Cash conversion
    -413.0%
    CapEx / revenue
    -1.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-0,9 %Bottom quartile
    Net Margin-1,4 %Bottom quartile
    ROE-1,4 %Bottom quartile
    Capex / Rev-1,4 %Above P75
    D/E0,66Below median
    Cash Conv-4,13Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Krynica Vitamin SA Market data — financials · 2026-05-28
    • Krynica Vitamin SA Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Leadership

    • Anna SwiderskaMember of the Management Board
    • Sylwia WysotaMember of the Management Board
    • Wojciech PiotrowskiMember of the Management Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    KVT.WACanonical
    Warsaw Stock Exchange · PLN

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2020-03-30 18:57 UTCEARNINGSAnnual results — FY 2020 Revenue PLN 356.3M · Net PLN 12.0M
    2019-11-12 16:25 UTCEARNINGSQuarterly results — Q3 2019 Revenue PLN 100.8M · Net PLN 5.0M
    2019-08-26 18:03 UTCEARNINGSQuarterly results — Q2 2019 Revenue PLN 107.4M · Net PLN 6.3M
    2019-05-13 16:14 UTCEARNINGSQuarterly results — Q1 2019 Revenue PLN 79.6M · Net PLN 0.9M
    2019-03-26 08:03 UTCEARNINGSQuarterly results — Q4 2018 Revenue PLN 86.3M · Net PLN 0.7M
    2019-03-26 08:03 UTCEARNINGSAnnual results — FY 2019 Revenue PLN 387.9M · Net PLN 12.2M
    2018-11-12 21:37 UTCEARNINGSQuarterly results — Q3 2018 Revenue PLN 112.9M · Net PLN 6.6M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage